0041Great Eagle Holdings Limited

🇭🇰 Hong Kong Borsası
13.68
HKD
Analysis Scores
Lothien Robustness Score?
69/100
Strong
Neden bu skor?
Damodaran ?
62/100
Dalio Risk ?
60/100
Piotroski ?
5/9
Neutral
Graham ?
Negatif HBK
Company is loss-making (EPS = -2.2125 TL) — Graham formula requires positive earnings
Active Metric?
2/4
Confidence?
56%
Lothien Robustness Summary
42/100
Lothien Sağlamlık: Zayıf (42/100)
Olumsuz göstergeler ağır basıyor. Finansal yapıda zayıflıklar mevcut. | Kısa Vade: Nötr | Uzun Vade: Nötr | Pozitif: 3 | Negatif: 2 | Nötr: 1
Net Zarar
Son çeyrekte -HK$414M zarar açıklandı. Yatırımcı dikkatli olmalı.
Kâr Stabil
Net kâr bir önceki çeyreğe göre fazla değişmedi (%+0.0). İstikrarlı seyir.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+80.7 arttı. Şirket büyüyor.
Defter Değerinin Altında
PD/DD: 0.20. Hisse defter değerinin altında işlem görüyor. Değer tuzağı mı yoksa fırsat mı iyi analiz edilmeli.
Negatif ROE
ROE: %-1.6. Şirket özsermayesini eritiyor.
Sonraki Çeyrek: Artış Beklentisi
Pusla tahminine göre bir sonraki çeyrekte kâr %+43.2 artabilir (-HK$414M → -HK$235M).

Data date 2026-10-23 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-23
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Orta
252 days
Annual Volatility ?
%22.3
VaR 95% ?
%2.32
daily max loss
VaR 99% ?
%3.28
daily max loss
CVaR 95% ?
%3.20
expected loss (tail)
Max Drawdown ?
%29.0
12.05.2026 → 06.10.2026
Skewness ?
-0.40
Parametrik%2.32
Historik%2.37
Cornish-Fisher%2.41
Return Distribution
Valuation
Potential?
+112.0%
ROIC ?
2.8%
DCF Value ?
402.06
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/6
Son 6 çeyrek ardışık zarar
Fiyat TRAMA-99 altında: %-10.9 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 15.35 HKD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %-8.4
Net profit margin %-8.4 — loss period. Compared to previous quarter +0.0 point increase.
ROE - Return on Equity (TTM) %-1.6
ROE %-1.6 — negative return on equity.
EBITDA Margin %-1.3
EBITDA margin %-1.3 — operational loss.
Gross Profit Margin %20.1
Gross profit per revenue %20.1. Evaluate relative to sector.
Free Cash Flow Margin (TTM) %35.8
TTM Free Cash Flow is %35.8'i. Strong FCF generation — profit quality is high.
Valuation
P/B Ratio 0.20x Sector: 2.22x
PD/DD 0.20x — sector median's (2.22x) well below. Cheap relative to book value.
Indebtedness
Current Ratio 1.77x
Current ratio 1.77x — can comfortably cover short-term debts.
Debt / Equity 0.59x
Debt/Equity 0.59x — moderate financial leverage.
Interest Coverage -0.2x
Interest coverage -0.2x — critical level. Risk of difficulty in interest payments.
Growth
Revenue Growth (YoY) %+80.7
Revenue YoY %80.7 grew (2025/12) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %+4.6
Loss %4.6 decreased — improvement continues.
Score Explanations
Lothien Robustness
69/100
Good robustness (69/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+112.0%
Plus %112.0 expected value (29.00) vs current price comparison. 2/4 valuation models could be calculated. Model confidence %56.
Components: P/B target: 41.04 | DCF target: 41.04
Damodaran Valuation
62/100
Moderate Damodaran score (62/100). ROIC (%2.8) – WACC (%5.4) difference -2.6 bps. Value creation capacity limited.
Moderate
Dalio Risk Analysis
60/100
Moderate debt risk (60/100). Interest coverage ratio -0.2x — weak, fragile.
Leverage: 80/100 | Debt Service: 89/100 | Quality: 53/100
ROIC - Return on Capital
%2.8
ROIC (%2.8) cost of capital (5.4%) below → destroying value.
WACC: %5.4
DCF Discounted Cash Flow
402.06
DCF modeli 402.06 target value produced — compared to current price %2839.1 undervalued.
Current price: 13.68
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
5/9
Moderate Piotroski (5/9). Some balance sheet criteria met, some missing.
Neutral
Graham Intrinsic Value
—
Company is loss-making (EPS = -2.2125 TL) — Graham formula requires positive earnings
⚖️ Sector Comparison
P/B Ratio
0.20x vs 2.22x
Compared to sector %91 cheaper (by book value)
ROIC vs WACC
%2.8 vs %5.4 WACC
ROIC 2.6 bps below cost of capital
Net Profit Margin (TTM)
%-8.4 vs %-1.3 EBITDA margin
TTM net profit margin %-8.4
TRAMA-99 Trend — Downtrend
Price (13.68), TRAMA-99 line's %10.9 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 13.68
TRAMA: 15.35
Difference: %-10.9
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
0041 — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.